Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 3.2B | 3.0B | 2.8B | 3.1B |
Cost of revenue | 969.5M | 832.6M | 800M | 872.1M |
Gross profit | 2.2B | 2.2B | 2.0B | 2.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 167.8M | 165.5M | 105.2M | 57.3M |
Operating income | 2.0B | 2.0B | 1.9B | 2.1B |
Non operating interest income | ||||
Income | 42.5M | 47.7M | 42.8M | 36.7M |
Expense | 3.8M | 7.6M | 12.4M | 21.4M |
Other income expense | — | — | — | — |
Pretax income | 1.9B | 2.1B | 1.6B | 2.1B |
Tax provision | 1.6B | 1.5B | 1.5B | 1.6B |
Net income | 316.1M | 561.8M | 173.4M | 531.3M |
Basic EPS | 0.5 | 0.9 | 0.3 | 0.8 |
Diluted EPS | 0.5 | 0.9 | 0.3 | 0.8 |
Basic average shares | 61.1M | 61.1M | 61.0M | 61.4M |
Diluted average shares | 61.1M | 61.1M | 61.0M | 61.4M |
EBITDA | 2.4B | 2.9B | 2.2B | 3.0B |
Net income from continuing op. | 1.9B | 2.1B | 1.6B | 2.1B |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |